RBC Capital Downgrades PTC Therapeutics (PTCT) to Sector Perform
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $81.33 -4.15%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Join SI Premium – FREE
RBC Capital downgraded PTC Therapeutics (NASDAQ: PTCT) from Outperform to Sector Perform with a price target of $11.00 (from $56.00).
For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.
Shares of PTC Therapeutics closed at $10.84 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Downgrades HCL Technologies (HCLT:IN) to Sell
- Jefferies Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Hold
- Q32 Bio Inc. (QTTB) PT Raised to $36 at Mizuho
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
